Literature DB >> 20643661

Congenital heart defects are under-recognised in adult patients with Down's syndrome.

Jeroen C Vis1, Rianne H de Bruin-Bon, Berto J Bouma, Sylvia A Huisman, Luc Imschoot, Kathleen van den Brink, Barbara J Mulder.   

Abstract

BACKGROUND: Congenital heart defects (CHD) are common in patients with Down's syndrome; however, patients living in residential centres have not always been screened for CHD in the past. The aim of this study was to investigate the prevalence of CHD in patients with Down's syndrome living in residential centres, and to determine whether cardiac screening should be recommended.
METHODS: Between January 2007 and November 2009 Dutch residential centres nationwide were randomly sampled. Medical files of all patients with Down's syndrome were investigated to retrieve documented information on known CHD. Echocardiography was performed on patients with unknown cardiac status. The main outcome measure was the number of newly diagnosed cases of CHD in adult patients with Down's syndrome.
RESULTS: Thirty-one centres and 1158 patients were included in the first stage of the study. Overall prevalence of known CHD was 16% (189 defects). Screening was performed in 138 patients without known CHD. In total, 24 new patients (17%) with a CHD were found, of which six patients needed semi-urgent care. Furthermore, 77% of the screened patients had mild to moderate regurgitation in one or more heart valves. Overall prevalence of CHD in adult Down's syndrome patients living in residential centres would be estimated at 33%.
CONCLUSIONS: Seventeen per cent of patients with Down's syndrome living in residential centres had undiagnosed CHD, and valvular regurgitation was present in the majority of patients. Cardiac screening is recommended in older Down's syndrome patients, for whom new therapeutic options are available and for prevention of cardiac complications in old age.

Entities:  

Mesh:

Year:  2010        PMID: 20643661     DOI: 10.1136/hrt.2010.197509

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  5 in total

1.  Prevalence of unsuspected abnormal echocardiograms in adolescents with down syndrome.

Authors:  Sarah B Clauss; Samuel S Gidding; Claire I Cochrane; Rachel Walega; Babette S Zemel; Mary E Pipan; Sheela N Magge; Andrea Kelly; Meryl S Cohen
Journal:  Am J Med Genet A       Date:  2019-10-06       Impact factor: 2.802

2.  The App-Runx1 region is critical for birth defects and electrocardiographic dysfunctions observed in a Down syndrome mouse model.

Authors:  Matthieu Raveau; Jacques M Lignon; Valérie Nalesso; Arnaud Duchon; Yoram Groner; Andrew J Sharp; Doulaye Dembele; Véronique Brault; Yann Hérault
Journal:  PLoS Genet       Date:  2012-05-31       Impact factor: 5.917

3.  Low Rates of Preventive Healthcare Service Utilization Among Adolescents and Adults With Down Syndrome.

Authors:  Kristin M Jensen; Elizabeth J Campagna; Elizabeth Juarez-Colunga; Allan V Prochazka; Desmond K Runyan
Journal:  Am J Prev Med       Date:  2020-11-12       Impact factor: 5.043

4.  Decrease in quality of life predicts mortality in adult patients with pulmonary arterial hypertension due to congenital heart disease.

Authors:  I M Blok; A C M J van Riel; M J Schuuring; M G Duffels; J C Vis; A P J van Dijk; E S Hoendermis; B J M Mulder; B J Bouma
Journal:  Neth Heart J       Date:  2015-05       Impact factor: 2.380

5.  The impact of trisomy 21 on treatment modalities and outcome in adults with congenital heart disease in Switzerland.

Authors:  Judith Johannes; Matthias Greutmann; Daniel Tobler; Judith Bouchardy; Dominik Stambach; Kerstin Wustmann; Fabienne Schwitz; Markus Schwerzmann
Journal:  Pulm Circ       Date:  2018-10-19       Impact factor: 3.017

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.